Swedish Orphan Biovitrum AB
Sustainability Report and Carbon Intensity Rankings
Is Swedish Orphan Biovitrum AB doing their part?
Their DitchCarbon score is 49
Swedish Orphan Biovitrum AB has a DitchCarbon Score of 49 out of 100, indicating a moderate level of sustainability in their operations. This score reflects the company’s carbon intensity, suggesting there is significant room for improvement in reducing emissions. A higher score would demonstrate a stronger commitment to lowering carbon intensity and enhancing sustainability efforts.
This was calculated based on 30+ company specific emissions data points, the higher the score, the better. Check out our methodology.
Industry emissions intensity
Very low
Low
Medium
High
Very high
Swedish Orphan Biovitrum AB is part of the industrial manufacturing sector, which has a carbon intensity ranking of very low. Some industries are more damaging than others, this ranking gives you an indication of how carbon intensive the industry is which this company operates in.
Location emissions intensity
Very low
Low
Medium
High
Very high
Swedish Orphan Biovitrum AB operates in Sweden, a country with a very low carbon intensity rating. This favorable environmental context supports the company’s sustainability efforts by reducing its carbon footprint.
Unlock 30+ emissions data points on Swedish Orphan Biovitrum AB
Get the emissions intelligence you need, no surveys required.
– Historical Scope 1, 2 and 3 emissions
– Coverage of all industries, product level data
– Emissions forecasting, assurances
Unlock 30+ emissions data points on Swedish Orphan Biovitrum AB
Get the emissions intelligence you need, no surveys required.
– Historical Scope 1, 2 and 3 emissions
– Coverage of all industries, product level data
– Emissions forecasting, assurances
7.71%
...this company is doing 7.71% better in emissions than the industry average.
Swedish Orphan Biovitrum AB, commonly known as Sobi, is a biopharmaceutical company based in Solna kommun, Sweden, founded in 2001. Operating within the industrial manufacturing sector, Sobi focuses on the development and delivery of innovative therapies for rare diseases, with a strong emphasis on Haemophilia and Specialty Care. The company markets a range of specialty products across various regions and is recognized for its expertise in protein biochemistry and biologics manufacturing.
emission intelligence's platform recommendations for Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB should foster supplier engagement initiatives to promote the reduction of emissions, potentially decreasing their Scope 3 emissions by 35%.
Bad news, Swedish Orphan Biovitrum has no SBTi commitment yet
Swedish Orphan Biovitrum AB has not yet established specific commitments with the Science Based Targets initiative (SBTi). This means the company is still in the process of defining clear, science-based emissions reduction targets to align with global efforts to mitigate climate change.
Not participating
Claim this profile
Are you associate with this company?
Help us improve our data and claim this profile.
Our methodology
Read about our emission calculation methodologies, and what the DitchCarbon Score means.
Looking for a specific company?
Search our company directory or contact us for custom data requests.